Survival with scleroderma—II: A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients
References (18)
- et al.
Survival with systemic sclerosis (scleroderma): a life-table analysis of demographic and clinical factors in 309 patients
Ann Int Med
(1971) - et al.
The epidemiology of systemic sclerosis (scleroderma)
Ann Int Med
(1971) Classification and pathogenesis of scleroderma
- et al.
Factors affecting survivorship in polymyositis: a life-table study of 124 patients
Arthritis Rheum
(1971) Evaluation of survival data and two new rank order statistics arising in its consideration
Cancer Chemother Rep
(1966)Multiple telangiectasia, Raynaud's phenomenon, sclerodactyly and subcutaneous calcinosis: syndrome mimicking hereditary hemorrhagic telangiectasia
Bull Johns Hopkins Hosp
(1964)- et al.
Systemic scleroderma: clinical study of 727 cases
Arch Derm (Chicago)
(1961)
Cited by (119)
Systemic Sclerodermas
2015, Textbook of Pediatric RheumatologyMortality and survival in systemic sclerosis: Systematic review and meta-analysis
2014, Seminars in Arthritis and RheumatismCitation Excerpt :This last data is obviously a more imprecise data but certainly more real. Several survival and mortality studies from single cohorts [1,3,8–79] and reviews have been published from the last mid-century, reporting data about cumulative survival at different times of follow-up and measured sometimes from the onset of disease and sometimes from the time of diagnosis. This is crucial at the time of meta-analyzing these data and to avoid any bias of selection.
Systemic Sclerosis and the Heart
2014, Rheumatic Disease Clinics of North AmericaCitation Excerpt :Significant cardiac involvement in SSc portends a poor prognosis. A study by Medsger and Masi10 in 1973 reported that patients with SSc with clinically apparent cardiac disease had an estimated 5-year mortality as high as 70%. Further analyses propose a lower mortality rate.
The systemic sclerodermas and related disorders
2011, Textbook of Pediatric RheumatologyApplication of cardiac magnetic resonance imaging in subclinical systemic sclerosis primary heart involvement
2024, Chinese Journal of Internal Medicine/Zhonghua Neike Zazhi
- ∗
Assistant Professor of Medicine and Community Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Dr. Medsger was a Research Associate in the VA Career Development Program and was located at the Memphis VA Hospital during the data collection phase of this study.
- †
Professor of Medicine and Director, Division of Connective Tissue Diseases, University of Tennessee College of Medicine, Memphis, Tennessee.